Heartflow (NASDAQ:HTFL) Sets New 52-Week High – What’s Next?

Shares of Heartflow, Inc. (NASDAQ:HTFL) reached a new 52-week high on Friday . The company traded as high as $52.22 and last traded at $51.2010, with a volume of 1599729 shares. The stock had previously closed at $49.57.

Wall Street Analyst Weigh In

HTFL has been the topic of several research reports. Canaccord Genuity Group upped their price objective on shares of Heartflow from $37.00 to $45.00 and gave the stock a “buy” rating in a report on Friday, August 14th. Piper Sandler reissued an “overweight” rating and issued a $45.00 price target (up from $38.00) on shares of Heartflow in a research report on Friday, August 14th. Freedom Capital raised Heartflow to a “strong-buy” rating in a report on Tuesday, June 30th. UBS Group began coverage on Heartflow in a report on Wednesday, September 9th. They set a “neutral” rating and a $55.00 price target on the stock. Finally, Morgan Stanley boosted their price objective on Heartflow from $35.00 to $40.00 and gave the stock an “equal weight” rating in a research report on Friday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $44.88.

Heartflow Stock Up 3.2%

The firm has a 50 day moving average of $37.27 and a 200 day moving average of $31.57. The firm has a market cap of $4.45 billion and a PE ratio of -27.99.

Heartflow (NASDAQ:HTFL) last issued its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) EPS for the quarter, beating analysts’ consensus estimates of ($0.22) by $0.15. The firm had revenue of $64.08 million for the quarter. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%.The firm’s revenue was up 47.7% on a year-over-year basis. On average, research analysts anticipate that Heartflow, Inc. will post -0.75 EPS for the current year.

Insider Activity at Heartflow

In related news, CEO John Farquhar sold 3,890 shares of Heartflow stock in a transaction that occurred on Friday, September 11th. The shares were sold at an average price of $50.00, for a total value of $194,500.00. Following the completion of the transaction, the chief executive officer directly owned 321,914 shares in the company, valued at approximately $16,095,700. The trade was a 1.19% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Vikram Verghese sold 668 shares of the business’s stock in a transaction on Tuesday, September 15th. The shares were sold at an average price of $50.01, for a total transaction of $33,406.68. Following the sale, the chief financial officer directly owned 179,528 shares in the company, valued at $8,978,195.28. The trade was a 0.37% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 282,640 shares of company stock worth $12,015,412. Insiders own 7.70% of the company’s stock.

Hedge Funds Weigh In On Heartflow

Hedge funds have recently made changes to their positions in the stock. Integrated Wealth Concepts LLC purchased a new stake in Heartflow during the 2nd quarter worth about $53,000. Essential Partners LLC purchased a new position in Heartflow during the 1st quarter valued at about $57,000. Caitong International Asset Management Co. Ltd bought a new stake in shares of Heartflow during the fourth quarter valued at about $72,000. Strs Ohio lifted its holdings in shares of Heartflow by 35.3% in the first quarter. Strs Ohio now owns 4,600 shares of the company’s stock worth $112,000 after buying an additional 1,200 shares in the last quarter. Finally, Bessemer Group Inc. bought a new position in shares of Heartflow in the first quarter valued at approximately $126,000.

About Heartflow

Heartflow, Inc is a medical technology company that develops artificial intelligence and imaging solutions for the diagnosis and management of coronary artery disease. Its platform analyzes data from coronary computed tomography angiography (CCTA) scans to create personalized, three-dimensional models of a patient’s coronary arteries.

The company’s primary offering, Heartflow Analysis, is designed to provide noninvasive estimates of fractional flow reserve derived from computed tomography (FFR^CT).